GILENYA 0,25 mg, gélule — plaquettes thermoformées PVC PVDC aluminium de 28 gélules
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930165942 -
CIP7
3016594 -
CIS
68003070 -
Registration number
EU/1/11/677
What the source publishes
- Holder
- NOVARTIS EUROPHARM (IRLANDE)
- Active ingredients
- FINGOLIMOD, CHLORHYDRATE DE FINGOLIMOD
- Form
- gélule
- Package
- plaquettes thermoformées PVC PVDC aluminium de 28 gélules
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2018-11-22
- Prescription
- Prescription or restricted
Names this record is found by
- GILENYA 0,25 mg, gélule — plaquettes thermoformées PVC PVDC aluminium de 28 gélules
- GILENYA 0,25 mg, gélule
- FINGOLIMOD
- CHLORHYDRATE DE FINGOLIMOD
Complete source data
{
"cis": "68003070",
"cip7": "3016594",
"form": "gélule",
"name": "GILENYA 0,25 mg, gélule — plaquettes thermoformées PVC PVDC aluminium de 28 gélules",
"cip13": "3400930165942",
"holder": "NOVARTIS EUROPHARM (IRLANDE)",
"routes": [
"orale"
],
"holders": [
"NOVARTIS EUROPHARM (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "580.30",
"authorisedOn": "2018-11-22",
"compositions": [
{
"name": "FINGOLIMOD",
"nature": "FT",
"strength": "0,25 mg",
"linkageNumber": "1",
"substanceCode": "85211",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
},
{
"name": "CHLORHYDRATE DE FINGOLIMOD",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "97368",
"dosageReference": null,
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE",
"dispensingFee": "1.02",
"medicinePrice": "579.28",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "GILENYA 0,25 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquettes thermoformées PVC PVDC aluminium de 28 gélules",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2019-10-25",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"FINGOLIMOD",
"CHLORHYDRATE DE FINGOLIMOD"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription réservée aux spécialistes et services NEUROLOGIE",
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription initiale hospitalière annuelle",
"liste I",
"la première administration doit être effectuée en milieu hospitalier",
"prescription réservée aux spécialistes et services NEUROPEDIATRIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/11/677",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930165942"